Dahiyat Bassil I 4

What Happened

• Dahiyat Bassil I, a member of Kodiak Sciences, was granted 17,731 derivative shares on June 30, 2026. The Form 4 reports an acquisition at $0.00 (i.e., an equity award/derivative grant rather than a market purchase).
• This is a compensatory equity award (not a sale). The filing does not show a cash value at grant time; market value would depend on Kodiak’s share price when vested or settled.

Key Details

• Transaction date: 2026-06-30; Filing date: 2026-07-02 (timely).
• Reported acquisition: 17,731 shares at $0.00 (transaction code A = award/grant).
• Vesting: 100% vests upon the earlier of June 30, 2027 or one day prior to the issuer’s next annual meeting after the grant date, provided he continues to serve on the board (footnote).
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• No indication of a 10b5-1 plan, tax withholding, or immediate sale in this report.

Context

• This appears to be a routine board compensation award (equity-based) and does not represent an open-market buy or sale. Such awards are common for directors and reflect compensation rather than a direct signal about the insider’s view of near-term stock performance.